News Industry News Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar January 18, 2011
News Industry News Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease January 09, 2011
News Industry News Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia January 02, 2011